000 01439 a2200421 4500
005 20250515050028.0
264 0 _c20070222
008 200702s 0 0 eng d
022 _a0284-186X
024 7 _a10.1080/02841860600979013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLuster, Markus
245 0 0 _aActa Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.
_h[electronic resource]
260 _bActa oncologica (Stockholm, Sweden)
_c2006
300 _a1018-30 p.
_bdigital
500 _aPublication Type: Lecture; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypothyroidism
_xprevention & control
650 0 4 _aIodine Radioisotopes
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aThyroglobulin
_xblood
650 0 4 _aThyroid Hormones
_xblood
650 0 4 _aThyroid Neoplasms
_xblood
650 0 4 _aThyrotropin
_xeconomics
650 0 4 _aWhole Body Imaging
773 0 _tActa oncologica (Stockholm, Sweden)
_gvol. 45
_gno. 8
_gp. 1018-30
856 4 0 _uhttps://doi.org/10.1080/02841860600979013
_zAvailable from publisher's website
999 _c16690359
_d16690359